Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Hyo Rak Lee"'
Autor:
Jung Hoon Kim, Sang-Cheol Lee, Sung Yong Oh, Seo-Young Song, Namsu Lee, Eun Mi Nam, Soonil Lee, In Gyu Hwang, Hyo Rak Lee, Kyu Taek Lee, Sang-Byung Bae, Han Jo Kim, Joung Soon Jang, Do Hyoung Lim, Hyun Woo Lee, Seok Yun Kang, Jung Hun Kang
Publikováno v:
Cancer Communications, Vol 38, Iss 1, Pp 1-8 (2018)
Abstract Background Combination therapy with oxaliplatin, irinotecan, fluorouracil, and leucovorin (FOLFIRINOX) chemotherapy drastically improves survival of advanced pancreatic cancer patients. However, the efficacy of FOLFIRINOX as a second-line tr
Externí odkaz:
https://doaj.org/article/efeaf4f309c24711903ab4571f8c45c0
Autor:
Yoon Jung Jang, Sang Moo Lim, Inki Lee, Byung Hyun Byun, Ilhan Lim, Byung Il Kim, Chang Woon Choi, Seung-Sook Lee, Sung Hyun Yang, Im Il Na, Hyo-Rak Lee, Dong-Yeop Shin, Hye Jin Kang
Publikováno v:
Clinical Medicine Insights: Oncology, Vol 17 (2023)
Background: Radioimmunotherapy (RIT) is a rare treatment option for relapsed or refractory B-cell non-Hodgkin’s lymphoma (NHL). We investigated the safety and efficacy of 131 I-rituximab in patients with relapsed or refractory marginal zone lymphom
Externí odkaz:
https://doaj.org/article/87867d920217437ca93a712ec9b5dada
Autor:
Yoon Jung Jang, Sang Moo Lim, Inki Lee, Byung Hyun Byun, Ilhan Lim, Byung Il Kim, Chang Woon Choi, Seung‐Sook Lee, Cheolwon Suh, Dok Hyun Yoon, Inho Kim, Seung‐Hyun Nam, Mark Hong Lee, Jong Ho Won, Jee Hyun Kong, Seong Hyun Jeong, Suk Joong Oh, Keon Woo Park, Jae Joon Han, Moo‐Kon Song, Sung Hyun Yang, Im Il Na, Hyo‐Rak Lee, Dong‐Yeop Shin, Hye Jin Kang
Publikováno v:
Asia-Pacific Journal of Clinical Oncology.
Autor:
Seo Yun Kim, Hyo-Rak Lee, Cheol Hyeon Kim, Hye Jin Kang, Hyesil Seol, Yoon Jung Jang, Sung Hyun Yang, Hong Kyu Jung, Hye-Ryoun Kim, Im Il Na
Publikováno v:
Translational Cancer Research
Background The incidence of second primary lung cancer (SPLC) is increasing with longer survival rates from breast cancer. Despite of studies to suggest the mutual exclusivity of epidermal growth factor receptor (EGFR) and human epidermal growth rece
Autor:
Yoon Jung Jang, Sang Moo Lim, Inki Lee, Byung Hyun Byun, Ilhan Lim, Byung Il Kim, Chang Woon Choi, Seung-Sook Lee, Sung Hyun Yang, Im Il Na, Hyo-Rak Lee, Dong-Yeop Shin, Hye Jin Kang
Publikováno v:
Clinical Medicine Insights: Oncology; Jan-Dec2023, Vol. 17, p1-7, 7p
Autor:
Sang-Hee Cho, Min-Hee Ryu, Keun-Wook Lee, Ho-Suk Oh, Sook Ryun Park, Hye Sook Han, Jin Won Kim, Byung-Ho Nam, Bong-Gun Seo, Ik-Joo Chung, Yoon-Koo Kang, Jae-Cheol Jo, Kyung Hee Lee, Hyo Rak Lee, Young Iee Park
Publikováno v:
Gastric Cancer. 24:156-167
In East Asia, S-1 plus cisplatin (SP) is one of the standard first-line chemotherapy regimens for metastatic or recurrent gastric cancer (MRGC). Oxaliplatin is generally less toxic and more convenient to administer than cisplatin. This was a multicen
Autor:
Eun Mi Nam, Joon Oh Park, Hyo Rak Lee, Young Suk Park, Sung Yong Oh, Joung Soon Jang, Hyun Jung Jun, Kyong Choun Chi, Suee Lee, In Gyu Hwang, Myung Hwan Rho
Publikováno v:
Cancer Chemotherapy and Pharmacology. 75:757-762
We conducted a phase II trial of 5-fluorouracil and oxaliplatin combination chemotherapy as a second-line treatment in unresectable/metastatic biliary tract cancer patients who had failed gemcitabine-based chemotherapy. Patients treated with gemcitab
Autor:
Jeeyun Lee, Seung Tae Kim, Se Hoon Park, Joon Oh Park, Young Suk Park, Hyo Rak Lee, Ho Yeong Lim, Sang Cheol Lee, Jung Hun Kang, Keon Woo Park, In Gyu Hwang, Won Ki Kang
Publikováno v:
European Journal of Cancer. 50:2822-2830
Purpose We aimed to the addition of synthetic 3-hydroxy-3-methyglutaryl coenzyme A (HMG-CoA) reductase inhibitor, simvastatin to capecitabine–cisplatin (XP) in patients with previously untreated advanced gastric cancer (AGC). Methods In this double
Autor:
In Gyu Hwang, Jung Hun Kang, Hyo Rak Lee, Joung Soon Jang, Sung Yong Oh, Eun Mi Nam, Do Hyoung Lim, Seok Yun Kang, Soon Il Lee, Jung Hoon Kim, Sang Byung Bae, Nam-Su Lee, Kyu Taek Lee, Seo Young Song, Han Jo Kim, Hyun Woo Lee, Sang Cheol Lee
Publikováno v:
Cancer Communications, Vol 38, Iss 1, Pp 1-8 (2018)
Background Combination therapy with oxaliplatin, irinotecan, fluorouracil, and leucovorin (FOLFIRINOX) chemotherapy drastically improves survival of advanced pancreatic cancer patients. However, the efficacy of FOLFIRINOX as a second-line treatment a
Autor:
Jun Ho Ji, Su Jin Lee, Ho Yeong Lim, Seung Tae Kim, Young Suk Park, Se Hoon Park, Joon Oh Park, Hyo Rak Lee, In Gyu Hwang, Kyong Choun Chi, Hui-Young Lee, Won Ki Kang, Jeeyun Lee, Jung Hun Kang, Suk Won Park
Publikováno v:
Journal of geriatric oncology. 8(3)
Objectives More than half of cases of gastric cancer (GC) are diagnosed in elderly patients (≥70years). While doublet combination with fluoropyrimidines and platinum is currently considered standard first-line chemotherapy in advanced GC, the main